Summit dismisses chief executive
This article was originally published in Clinica
Executive Summary
Summit Technology has terminated the employment of chief executive and chairman David Muller. A spokeswoman told Clinica the reasons were related to his performance. Mr Muller founded the excimer laser company in 1985 but saw its share price drop from more than $38 last December to $5.25 at the close on September 10th. Summit's board has appointed an executive committee chaired by Verne Sharma who will also serve as interim CEO.
You may also be interested in...
Sanofi Clinches Key Phase III Immunology Win With Rilzabrutinib
Sanofi’s BTK inhibitor – one of two from its 2021 Principia buy – passed a Phase III test in immune thrombocytopenia as the company focuses on Dupixent-like blockbusters going forward.
US FDA Gene Therapy Accelerated Approval Guidance Will Describe ‘Buckets’ Of Use Scenarios
Forthcoming guidance is expected to describe areas of “low-hanging fruit” and those that are more challenging for use of the expedited pathway, Center for Biologics Evaluation and Research Director Peter Marks said.
FTC Early Findings In PBM Investigation Coming By Mid-Summer, Chair Kahn Says
The agency is also poised to announce another development in its scrutiny of the drug patents listed in the FDA’s Orange Book.